new pre-clinical research on rnai

Encouraging data are immerging in the field of RNAi of late.
The following link has yesterday been released by Alnylam.

http://www.smartbrief.com/news/aaaa/industryBW-detail.jsp?id=14AD7E1E-E359-4A6B-827B-91256141045D

The importance for Benitec is that Alnylam have a reciprocal agreement with them to use their technology in their trials. And gives further validation that the technology works.

here is a snippet:

"in vivo non-human primate data showing durable silencing of PCSK9 for more than 30 days following a single dose administration, with reduction in LDL cholesterol levels of approximately 50%;"